Zelira Therapeutics Ltd has released a press release.
US Observational Clinical Pain Trial Receives IRB Approval
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Cantor Fitzgerald - Investor Presentation
- Research Demonstrates Significant Uptake of CBD Into Brain
- Zelira to Launch CBD Toothpaste in the United Kingdom
- ZLD and Levin Health to Conduct Chronic Pain Clinical Trial
- Zeliras HOPE Range of Products Launches in Washington DC
Later from Zelira Therapeutics
- June 2021 Quarterly Activities Report
- Appendix 4C - quarterly
- Zelira enters Germany via Exclusive Distribution Agreement
- Zelira Launches RAF FIVE Acne Treatment Products
- Zelira Raises US$5 Million from US Fund
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics